Sybren Meyer

3.8k total citations · 2 hit papers
27 papers, 2.9k citations indexed

About

Sybren Meyer is a scholar working on Surgery, Immunology and Molecular Biology. According to data from OpenAlex, Sybren Meyer has authored 27 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Sybren Meyer's work include Immune Response and Inflammation (6 papers), Immunotherapy and Immune Responses (5 papers) and Clinical Nutrition and Gastroenterology (4 papers). Sybren Meyer is often cited by papers focused on Immune Response and Inflammation (6 papers), Immunotherapy and Immune Responses (5 papers) and Clinical Nutrition and Gastroenterology (4 papers). Sybren Meyer collaborates with scholars based in Netherlands, Germany and Belgium. Sybren Meyer's co-authors include Mitsuru Sasako, M.F. von Meyenfeldt, K Welvaart, D. J. Gouma, Peter W. de Graaf, H. Obertop, C. W. Taat, Ilfet Songun, Johannes J. Bonenkamp and J. Hermans and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Annals of Surgery.

In The Last Decade

Sybren Meyer

27 papers receiving 2.8k citations

Hit Papers

Extended Lymph-Node Dissection for Gastric Cancer 1995 2026 2005 2015 1999 1995 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sybren Meyer Netherlands 16 2.0k 1.2k 1.0k 559 243 27 2.9k
Kimihiko Yanaoka Japan 21 2.2k 1.1× 1.8k 1.5× 859 0.8× 845 1.5× 220 0.9× 38 3.5k
Satoshi Tanabe Japan 34 3.1k 1.6× 2.2k 1.9× 1.4k 1.4× 860 1.5× 90 0.4× 185 4.4k
Hiroyuki Osawa Japan 31 1.2k 0.6× 2.0k 1.7× 686 0.7× 667 1.2× 261 1.1× 118 3.3k
Hiroyasu Makuuchi Japan 29 2.0k 1.0× 2.4k 2.0× 542 0.5× 1.5k 2.7× 219 0.9× 312 4.2k
Kazutaka Obama Japan 30 1.7k 0.9× 1.4k 1.2× 838 0.8× 758 1.4× 111 0.5× 176 2.9k
Mikihito Nakamori Japan 29 1.3k 0.6× 1.0k 0.9× 651 0.6× 747 1.3× 386 1.6× 119 2.5k
Daisuke Korenaga Japan 31 2.0k 1.0× 1.7k 1.4× 785 0.8× 1.2k 2.1× 160 0.7× 138 3.9k
Makoto Iwahashi Japan 27 862 0.4× 825 0.7× 365 0.4× 801 1.4× 514 2.1× 128 2.3k
Hideyuki Tamai Japan 26 1.1k 0.6× 1.5k 1.3× 365 0.4× 326 0.6× 172 0.7× 92 2.3k
Enqiang Linghu China 27 994 0.5× 1.4k 1.2× 741 0.7× 597 1.1× 148 0.6× 275 2.6k

Countries citing papers authored by Sybren Meyer

Since Specialization
Citations

This map shows the geographic impact of Sybren Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sybren Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sybren Meyer more than expected).

Fields of papers citing papers by Sybren Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sybren Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sybren Meyer. The network helps show where Sybren Meyer may publish in the future.

Co-authorship network of co-authors of Sybren Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Sybren Meyer. A scholar is included among the top collaborators of Sybren Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sybren Meyer. Sybren Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meyer, Sybren, et al.. (2010). Indikation und Ausmaß der zervikalen Lymphadenektomie beim differenzierten Schilddrüsenkarzinom. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 136(4). 364–373. 1 indexed citations
2.
Bonenkamp, Johannes J., J. Hermans, Mitsuru Sasako, et al.. (1999). Extended Lymph-Node Dissection for Gastric Cancer. New England Journal of Medicine. 340(12). 908–914. 1178 indexed citations breakdown →
3.
Honkoop, Aafke H., Sylvia A. Luykx‐de Bakker, Klaas Hoekman, et al.. (1999). Prolonged Neoadjuvant Chemotherapy with GM-CSF in Locally Advanced Breast Cancer. The Oncologist. 4(2). 106–111. 36 indexed citations
4.
Eestermans, I.L., et al.. (1998). Milky spots in the greater omentum are predominant sites of local tumour cell proliferation and accumulation in the peritoneal cavity. Cancer Immunology Immunotherapy. 47(4). 205–212. 52 indexed citations
5.
Wiezer, Marinus J., Robert J. Bauer, Mark White, et al.. (1998). PHARMACOKINETICS OF A RECOMBINANT AMINO TERMINAL FRAGMENT OF BACTERICIDAL/PERMEABILITY INCREASING PROTEIN (rBPI21) AFTER LIVER SURGERY IN RATS AND HUMANS. Shock. 10(3). 161–166. 15 indexed citations
6.
Houdijk, Alexander P. J., Catharina Meijer, Miguel A. Cuesta, Sybren Meyer, & Paul A.M. van Leeuwen. (1997). Perioperative Anti-endotoxin Strategies. Scandinavian Journal of Gastroenterology. 32(sup222). 93–97. 9 indexed citations
7.
Koenen, Hans J. P. M., Wim Calame, J.J. van der Harten, et al.. (1997). Ontogeny of milky spots in the human greater omentum: An immunochemical study. The Anatomical Record. 249(3). 399–404. 33 indexed citations
9.
Eestermans, I.L., et al.. (1995). Cellular composition of milky spots in the human greater omentum: An immunochemical and ultrastructural study. The Anatomical Record. 241(2). 163–174. 90 indexed citations
11.
Koenen, Hans J. P. M., et al.. (1995). Novel isolation and purification method permitting functional cytotoxicity studies of macrophages from milky spots in the greater omentum. Journal of Immunological Methods. 184(2). 253–261. 15 indexed citations
12.
Leeuwen, Paul A.M. van, Marja A. Boermeester, Sybren Meyer, et al.. (1995). Pretreatment with Enteral Cholestyramine Prevents Suppression of the Cellular Immune System After Partial Hepatectomy. Annals of Surgery. 221(3). 282–290. 10 indexed citations
13.
Schuurman, Bart, Robert H.J. Beelen, Gijsbert Heuff, et al.. (1995). Fresh colorectal tumor cells isolated from individual patients differ in their susceptibility to monocyte mediated cytotoxicity. Journal of Surgical Oncology. 60(1). 18–23. 2 indexed citations
14.
Bonenkamp, Johannes J., Ilfet Songun, K Welvaart, et al.. (1995). Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. The Lancet. 345(8952). 745–748. 809 indexed citations breakdown →
15.
Schuurman, Bart, Gijsbert Heuff, R.H.J. Beelen, & Sybren Meyer. (1994). Enhanced killing capacity of human Kupffer cells after activation with human granulocyte/macrophage-colony-stimulating factor and interferon ?. Cancer Immunology Immunotherapy. 39(3). 179–184. 32 indexed citations
16.
Eestermans, I.L., et al.. (1994). An ultrastructural study of dopamine-immunoreactive nerve fibres in milky spots of the human greater omentum. Neuroscience Letters. 168(1-2). 143–146. 5 indexed citations
17.
Heuff, Gijsbert, et al.. (1993). Isolation of cytotoxic Kupffer cells by a modified enzymatic assay: a methodological study. Journal of Immunological Methods. 159(1-2). 115–123. 19 indexed citations
18.
Heuff, Gijsbert, Hester S. A. Oldenburg, H. Boutkan, et al.. (1993). Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells. Cancer Immunology Immunotherapy. 37(2). 125–130. 86 indexed citations
19.
Peters, Godefridus J., J. Lankelma, Rob Kok, et al.. (1993). Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma. Cancer Chemotherapy and Pharmacology. 31(4). 269–276. 95 indexed citations
20.
Bril, Herman, et al.. (1989). Cell-mediated immunity is enhanced by cytostatic drugs continuously released at the site of antigenic stimulation. Cancer Immunology Immunotherapy. 28(2). 131–5. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026